Psychotomimetism

Psychotomimetism is a term used in psychopharmacology to describe the effects of certain drugs that mimic the symptoms of psychosis, including hallucinations, delusions, and disordered thinking. The term is derived from the Greek words "psyche" (mind) and "mimesis" (imitation).

History

The term "psychotomimetic" was coined by the psychiatrist Louis Jolyon West in 1954 to describe the effects of the drug LSD. West was interested in the potential of LSD and similar drugs to produce a temporary state of psychosis in healthy individuals, which could then be studied to gain insights into the nature of psychotic disorders.

Drugs

Drugs that are considered psychotomimetic include hallucinogens such as LSD, psilocybin, and mescaline, as well as dissociative drugs like ketamine and phencyclidine (PCP). These drugs can produce a wide range of effects, including perceptual distortions, hallucinations, delusions, and cognitive impairment.

Research

Research into psychotomimetic drugs has provided valuable insights into the neurobiology of psychosis. For example, studies have shown that these drugs can induce changes in brain activity that are similar to those seen in individuals with schizophrenia and other psychotic disorders. This has led to the development of new theories about the underlying causes of these disorders, as well as new approaches to treatment.

See also

• Psychedelic drug
• Dissociative
• Hallucinogen
• Deliriant

References

Psychotomimetism Resources
Latest articles Most recent articles Ongoing trials	Wikipedia